Quick Overview: Matthew Ulrickson, MD, Banner MD Anderson Cancer Center, Gilbert, AZ, briefly discusses potential combination strategies that ... Cathy Burton, MB BChir, MD, MRCP, FRCPath, St James's University Hospital, Leeds, UK, outlines strategies for enhancing ... In this video, Bijal Shah, MD, Moffitt Cancer Center, Tampa, FL, discusses the need to identify strategies to

Optimizing Car T Outcomes In - Detailed Overview & Context

Matthew Ulrickson, MD, Banner MD Anderson Cancer Center, Gilbert, AZ, briefly discusses potential combination strategies that ... Cathy Burton, MB BChir, MD, MRCP, FRCPath, St James's University Hospital, Leeds, UK, outlines strategies for enhancing ... In this video, Bijal Shah, MD, Moffitt Cancer Center, Tampa, FL, discusses the need to identify strategies to In this interview, Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, comments on ... David Miklos, MD, PhD, Stanford University, Stanford, CA, comments on the importance of Whilst lymphodepletion chemotherapy enhances the efficacy of

Interview with Luciano Costa, MD, PhD, from University Of Alabama At Birmingham, recorded on September 26, 2024 at the IMS ... Noelle V. Frey, MD, discusses the challenges of balancing the promises of chimeric antigen receptor Bijal Shah, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses ways in which chimeric antigen receptor ... Prasad Adusumilli, MD, FACS, Memorial Sloan Kettering Cancer Center, New York, NY, describes strategies to Michel Delforge, MD, PhD, University of Leuven, Leuven, Belgium, discusses possible strategies to Optimal directions for chimeric antigen receptor (

In this video, Doris Hansen, MD, Moffitt Cancer Center, Tampa, FL, briefly discusses strategies to Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, provides a comprehensive overview of the history and ... Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, explores potential avenues for improving chimeric ... Bijal Shah, MD, of the Moffitt Cancer Center, Tampa, FL, suggests ways in which chimeric antigen receptor T-cell ( During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held ... Jordan Gauthier, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, tells us how

Doris Hansen, MD, Moffitt Cancer Center, Tampa, FL, comments on the importance of bridging therapy prior to

Photo Gallery

Optimizing CAR-T outcomes in DLBCL: possible combination strategies & sequencing of agents
Improving survival outcomes and optimizing CAR-T therapy in patients with DLBCL
Exploring strategies to optimize post-CAR-T outcomes in patients with ALL
Optimizing bridging therapy strategies before CAR T-cell therapy
Optimizing CD19 CAR T-cell delivery for patients with R/R aggressive lymphoma
Optimizing lymphodepletion chemotherapy in CAR-T therapy recipients
Optimizing Outcomes in Early CAR-T Therapy | Luciano Costa, MD, PhD | IMS 2024
Optimizing CAR T-Cell Therapy in Relapsed/Refractory ALL
Optimizing CAR-T therapy
Optimizing CAR T-cell therapies for thoracic cancers
Strategies to optimize CAR-T therapy in myeloma: bringing CAR-T into earlier lines
Optimizing the Use of CAR T-Cell Therapy in Lymphoma
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored